Rafael Dias Romero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rafael Dias Romero has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Giulianno Molina de Melo
Universidade Federal de São Paulo, Escola Paulista de Medicina (UNIFESP/EPM), Department of Otorhinolaryngology and Surgery of Head and Neck, São Paulo, SP, Brazil; Hospital Beneficência Portuguesa de São Paulo, Department of Head and Neck Surgery, São Paulo, SP, Brazil
5 shared publications - Marcello Rosano
Universidade Federal de São Paulo, Escola Paulista de Medicina (UNIFESP/EPM), Department of Otorhinolaryngology and Surgery of Head and Neck, São Paulo, SP, Brazil; Hospital Beneficência Portuguesa de São Paulo, Department of Head and Neck Surgery, São Paulo, SP, Brazil
5 shared publications - Murilo Catafesta das Neves
Universidade Federal de São Paulo (UNIFESP), Department of Otorhinolaryngology and Head and Neck Surgery, São Paulo, SP, Brazil
5 shared publications - Arthur Paredes Gatti
Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil
2 shared publications - Barbara Greggio
Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil
2 shared publications - Fabiano Mesquita Callegari
Universidade Federal de Sao Paulo/ Escola Paulista de Medicina, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 16 April 2026
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 92 (4) , 101821
Sialendoscopy as treatment of face aesthetic surgery complications: technical note
- 16 April 2026
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 92 (4) , 101821
Open AccessSialendoscopy as treatment of face aesthetic surgery complications: technical note
- Open Access
- 27 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 404
Prognostic Factors of Locally Advanced Cutaneous Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing CSCC is 65–250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases, and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LACSCC) of the head and neck region in transplant patients. Methods: 16-year retrospective, single-center series of patients with LACSCC in the head and neck region who underwent surgical treatment. Clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence, and survival were analyzed. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. The most affected regions were malar/nasal (28.8%) and auricular (19.2%). Surgeries included wide resection with reconstruction (58.9%), exenteration (14.1%), and temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p = 0.009), transplanted (p = 0.006), compromised margin (p = 0.049); Mortality: immunosuppression (p = 0.028), total resection and reconstruction (p = 0.013), stage (8ed) III-IV (p < 0.001), compromised margin (p < 0.001), neck metastasis with extranodal extension (p = 0.018). Multivariate analysis: Recurrence: transplanted HR: 3.69 (p < 0.001), neck metastasis extranodal extension HR: 5.41 (p < 0.001), evolution to distant metastasis HR: 5.27 (p < 0.001); Mortality: neck metastasis extranodal extension HR: 1.94, (p = 0.032), compromised margins HR: 1.87 (p = 0.001). Main surgical procedures: temporalectomy HR: 2.83 (p = 0.007), major rhinectomy HR: 2.47 (p = 0.005); Worst overall survival: Tx compared to NonTx (p = 0.069); Worst survival with recurrence: Tx compared to NonTx (p = 0.005). Conclusions: The LACSCC and transplanted (immunosuppressed) group present low survival, worse prognosis; The formulation of specific guidelines to standardize treatment and predict outcomes on this population are strictly necessary.
- 27 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 404
Open AccessPrognostic Factors of Locally Advanced Cutaneous Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing CSCC is 65–250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases, and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LACSCC) of the head and neck region in transplant patients. Methods: 16-year retrospective, single-center series of patients with LACSCC in the head and neck region who underwent surgical treatment. Clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence, and survival were analyzed. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. The most affected regions were malar/nasal (28.8%) and auricular (19.2%). Surgeries included wide resection with reconstruction (58.9%), exenteration (14.1%), and temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p = 0.009), transplanted (p = 0.006), compromised margin (p = 0.049); Mortality: immunosuppression (p = 0.028), total resection and reconstruction (p = 0.013), stage (8ed) III-IV (p < 0.001), compromised margin (p < 0.001), neck metastasis with extranodal extension (p = 0.018). Multivariate analysis: Recurrence: transplanted HR: 3.69 (p < 0.001), neck metastasis extranodal extension HR: 5.41 (p < 0.001), evolution to distant metastasis HR: 5.27 (p < 0.001); Mortality: neck metastasis extranodal extension HR: 1.94, (p = 0.032), compromised margins HR: 1.87 (p = 0.001). Main surgical procedures: temporalectomy HR: 2.83 (p = 0.007), major rhinectomy HR: 2.47 (p = 0.005); Worst overall survival: Tx compared to NonTx (p = 0.069); Worst survival with recurrence: Tx compared to NonTx (p = 0.005). Conclusions: The LACSCC and transplanted (immunosuppressed) group present low survival, worse prognosis; The formulation of specific guidelines to standardize treatment and predict outcomes on this population are strictly necessary.
- Open Access
- 10 December 2025
- Published by MDPI AG in Preprints.org
Prognostic Factors of Locally Advanced Skin Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Squamous cell carcinoma of the skin (SCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing SCC is 65-250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LASCC) of the head and neck region in transplant patients. Methods:16-year retrospective, single-center series of patients with LASCC in the head and neck region who underwent surgical treatment. Were analyzed: clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence and survival. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. Most affected regions: malar/nasal (28.8%), auricular (19.2%). Surgeries: wide resection with reconstruction (58.9%), exenteration (14.1%), temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p=0.009), transplanted (p=0.006), compromised margin (p=0.049), Mortality: immunosuppression (p=0.028), Total Resection and reconstruction (p=0.013), Stage(8ed) III-IV (p<0.001), compromised margin (p<0.001), neck metastasis with extranodal extension (p=0.018). Multivariate analysis: Recurrence: Transplanted HR:3.69 (p<0.001), Neck metastasis extranodal extension HR:5.41 (p<0.001), Evolution to Distant metastasis HR:5.27 (p<0.001); Mortality: Neck metastasis extranodal extension HR:1.94, (p=0.032), Compromised Margins HR:1.87 (p=0.001), Main Surgical Procedures: Temporalectomy HR:2.83 (p=0.007); Major Rhinectomy HR:2.47 (p=0.005); Worst Overall Survival: Tx compared to NonTx (p=0.069), Worst Survival with Recurrence: Tx compared to NonTx (p=0.005). Conclusions: The LASCC and Transplanted (immunosuppressed) group present low survival, worse prognosis, high risk of recurrence and mortality outcome, formulation of specific guidelines to standardize treatment and predict outcomes in this population are strictly necessary.
- 10 December 2025
- Published by MDPI AG in Preprints.org
Open AccessPrognostic Factors of Locally Advanced Skin Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Squamous cell carcinoma of the skin (SCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing SCC is 65-250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LASCC) of the head and neck region in transplant patients. Methods:16-year retrospective, single-center series of patients with LASCC in the head and neck region who underwent surgical treatment. Were analyzed: clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence and survival. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. Most affected regions: malar/nasal (28.8%), auricular (19.2%). Surgeries: wide resection with reconstruction (58.9%), exenteration (14.1%), temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p=0.009), transplanted (p=0.006), compromised margin (p=0.049), Mortality: immunosuppression (p=0.028), Total Resection and reconstruction (p=0.013), Stage(8ed) III-IV (p<0.001), compromised margin (p<0.001), neck metastasis with extranodal extension (p=0.018). Multivariate analysis: Recurrence: Transplanted HR:3.69 (p<0.001), Neck metastasis extranodal extension HR:5.41 (p<0.001), Evolution to Distant metastasis HR:5.27 (p<0.001); Mortality: Neck metastasis extranodal extension HR:1.94, (p=0.032), Compromised Margins HR:1.87 (p=0.001), Main Surgical Procedures: Temporalectomy HR:2.83 (p=0.007); Major Rhinectomy HR:2.47 (p=0.005); Worst Overall Survival: Tx compared to NonTx (p=0.069), Worst Survival with Recurrence: Tx compared to NonTx (p=0.005). Conclusions: The LASCC and Transplanted (immunosuppressed) group present low survival, worse prognosis, high risk of recurrence and mortality outcome, formulation of specific guidelines to standardize treatment and predict outcomes in this population are strictly necessary.
- 6 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e68055
Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study
Sialolithiasis is a common cause of obstructive salivary gland disease, occurring in both submandibular and parotid glands. The treatment has evolved with the introduction of Sialendoscopy and micro-instruments (baskets, wires, and balloons), which allow intraductal manipulations, including stone removal and strictures, to be dilated. Nowadays, it is the main option for effectively treating these obstructive conditions, leading to improvements in overall quality of life. The objective of the present 10-year retrospective review is to standardize the basic steps involved in successfully removing intraductal sialolithiasis with a Basket instrument. A consecutive ten-year series (January/2014 to June/2024) of patients with obstructive submandibular and parotid glands due to sialolithiasis who underwent sialendoscopy using a basket successfully removed were analyzed. The procedure was conducted following the standards; all interventions were video-recorded and performed by the same surgical team using a semi-rigid modular sialendoscope (1.3 mm/1.7 mm diameter) with working channel, salivary probes, dilatators, different baskets (0.4 mm diameter and 3, 4 and 6 wires) for stones and dilatations, using some steps previously reported. In 10 years, we have performed 224 sialendoscopy due to salivary gland obstructive disease, 84.4% from sialolithiasis. The successful sialolith removal with the basket was performed using pure sialendoscopy (PS-study group) in 132 (69.8%) patients: 79.5% female patients, mean age 44.8 years; 68.9% in the submandibular gland, 65.9% single stones, with 0% major complications. The basic steps were a) how to localize; b) to evaluate (mobile/hard/single stone); c) to estimate sialolith size; d) to choose basket type; e) to choose approach technique (A: Frontal:9.1%, B: Side-to-Side: 35.6%, C: Back-to-Forward: 55.3%). All sialoliths were completely removed, and the patients recovered uneventfully. This article details the standardization of the use of basket in removing ductal stones during sialendoscopy, which is necessary to achieve a high success rate in its removal.
- 6 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e68055
Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study
Sialolithiasis is a common cause of obstructive salivary gland disease, occurring in both submandibular and parotid glands. The treatment has evolved with the introduction of Sialendoscopy and micro-instruments (baskets, wires, and balloons), which allow intraductal manipulations, including stone removal and strictures, to be dilated. Nowadays, it is the main option for effectively treating these obstructive conditions, leading to improvements in overall quality of life. The objective of the present 10-year retrospective review is to standardize the basic steps involved in successfully removing intraductal sialolithiasis with a Basket instrument. A consecutive ten-year series (January/2014 to June/2024) of patients with obstructive submandibular and parotid glands due to sialolithiasis who underwent sialendoscopy using a basket successfully removed were analyzed. The procedure was conducted following the standards; all interventions were video-recorded and performed by the same surgical team using a semi-rigid modular sialendoscope (1.3 mm/1.7 mm diameter) with working channel, salivary probes, dilatators, different baskets (0.4 mm diameter and 3, 4 and 6 wires) for stones and dilatations, using some steps previously reported. In 10 years, we have performed 224 sialendoscopy due to salivary gland obstructive disease, 84.4% from sialolithiasis. The successful sialolith removal with the basket was performed using pure sialendoscopy (PS-study group) in 132 (69.8%) patients: 79.5% female patients, mean age 44.8 years; 68.9% in the submandibular gland, 65.9% single stones, with 0% major complications. The basic steps were a) how to localize; b) to evaluate (mobile/hard/single stone); c) to estimate sialolith size; d) to choose basket type; e) to choose approach technique (A: Frontal:9.1%, B: Side-to-Side: 35.6%, C: Back-to-Forward: 55.3%). All sialoliths were completely removed, and the patients recovered uneventfully. This article details the standardization of the use of basket in removing ductal stones during sialendoscopy, which is necessary to achieve a high success rate in its removal.
- 6 June 2025
- Published by MyJove Corporation
- No. 220,p. e68055
JoVE Video Dataset
Sialolithiasis is a common cause of obstructive salivary gland disease, occurring in both submandibular and parotid glands. The treatment has evolved with the introduction of Sialendoscopy and micro-instruments (baskets, wires, and balloons), which allow intraductal manipulations, including stone removal and strictures, to be dilated. Nowadays, it is the main option for effectively treating these obstructive conditions, leading to improvements in overall quality of life. The objective of the present 10-year retrospective review is to standardize the basic steps involved in successfully removing intraductal sialolithiasis with a Basket instrument. A consecutive ten-year series (January/2014 to June/2024) of patients with obstructive submandibular and parotid glands due to sialolithiasis who underwent sialendoscopy using a basket successfully removed were analyzed. The procedure was conducted following the standards; all interventions were video-recorded and performed by the same surgical team using a semi-rigid modular sialendoscope (1.3 mm/1.7 mm diameter) with working channel, salivary probes, dilatators, different baskets (0.4 mm diameter and 3, 4 and 6 wires) for stones and dilatations, using some steps previously reported. In 10 years, we have performed 224 sialendoscopy due to salivary gland obstructive disease, 84.4% from sialolithiasis. The successful sialolith removal with the basket was performed using pure sialendoscopy (PS-study group) in 132 (69.8%) patients: 79.5% female patients, mean age 44.8 years; 68.9% in the submandibular gland, 65.9% single stones, with 0% major complications. The basic steps were a) how to localize; b) to evaluate (mobile/hard/single stone); c) to estimate sialolith size; d) to choose basket type; e) to choose approach technique (A: Frontal:9.1%, B: Side-to-Side: 35.6%, C: Back-to-Forward: 55.3%). All sialoliths were completely removed, and the patients recovered uneventfully. This article details the standardization of the use of basket in removing ductal stones during sialendoscopy, which is necessary to achieve a high success rate in its removal.
- 6 June 2025
- Published by MyJove Corporation
- No. 220,p. e68055
JoVE Video Dataset
Sialolithiasis is a common cause of obstructive salivary gland disease, occurring in both submandibular and parotid glands. The treatment has evolved with the introduction of Sialendoscopy and micro-instruments (baskets, wires, and balloons), which allow intraductal manipulations, including stone removal and strictures, to be dilated. Nowadays, it is the main option for effectively treating these obstructive conditions, leading to improvements in overall quality of life. The objective of the present 10-year retrospective review is to standardize the basic steps involved in successfully removing intraductal sialolithiasis with a Basket instrument. A consecutive ten-year series (January/2014 to June/2024) of patients with obstructive submandibular and parotid glands due to sialolithiasis who underwent sialendoscopy using a basket successfully removed were analyzed. The procedure was conducted following the standards; all interventions were video-recorded and performed by the same surgical team using a semi-rigid modular sialendoscope (1.3 mm/1.7 mm diameter) with working channel, salivary probes, dilatators, different baskets (0.4 mm diameter and 3, 4 and 6 wires) for stones and dilatations, using some steps previously reported. In 10 years, we have performed 224 sialendoscopy due to salivary gland obstructive disease, 84.4% from sialolithiasis. The successful sialolith removal with the basket was performed using pure sialendoscopy (PS-study group) in 132 (69.8%) patients: 79.5% female patients, mean age 44.8 years; 68.9% in the submandibular gland, 65.9% single stones, with 0% major complications. The basic steps were a) how to localize; b) to evaluate (mobile/hard/single stone); c) to estimate sialolith size; d) to choose basket type; e) to choose approach technique (A: Frontal:9.1%, B: Side-to-Side: 35.6%, C: Back-to-Forward: 55.3%). All sialoliths were completely removed, and the patients recovered uneventfully. This article details the standardization of the use of basket in removing ductal stones during sialendoscopy, which is necessary to achieve a high success rate in its removal.